Rainer Schulz

33.5k total citations · 3 hit papers
399 papers, 22.4k citations indexed

About

Rainer Schulz is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Rainer Schulz has authored 399 papers receiving a total of 22.4k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Cardiology and Cardiovascular Medicine, 152 papers in Pathology and Forensic Medicine and 122 papers in Molecular Biology. Recurrent topics in Rainer Schulz's work include Cardiac Ischemia and Reperfusion (150 papers), Cardiac Arrest and Resuscitation (68 papers) and Cardiac Imaging and Diagnostics (60 papers). Rainer Schulz is often cited by papers focused on Cardiac Ischemia and Reperfusion (150 papers), Cardiac Arrest and Resuscitation (68 papers) and Cardiac Imaging and Diagnostics (60 papers). Rainer Schulz collaborates with scholars based in Germany, Hungary and United States. Rainer Schulz's co-authors include Gerd Heusch, Kerstin Boengler, Péter Ferdinandy, Gary F. Baxter, Andreas Skyschally, Petra Kleinbongard, Derek J. Hausenloy, David García‐Dorado, Heiner Post and Petra Gres and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Circulation.

In The Last Decade

Rainer Schulz

390 papers receiving 22.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning

2007 580 citations Péter Ferdinandy, Rainer Schulz et al. Pharmacological Reviews profile →
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury

2019 521 citations Sean M. Davidson, Péter Ferdinandy et al. profile →
Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning

2014 462 citations Péter Ferdinandy, Derek J. Hausenloy et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rainer Schulz Germany	78	8.1k	8.0k	7.8k	3.9k	3.0k	399	22.4k
Roberto Bolli United States	98	10.4k 1.3×	13.0k 1.6×	12.0k 1.5×	5.7k 1.5×	4.5k 1.5×	416	32.7k
Gerd Heusch Germany	94	14.2k 1.7×	12.6k 1.6×	7.9k 1.0×	6.6k 1.7×	3.3k 1.1×	538	30.8k
Derek J. Hausenloy United Kingdom	84	9.4k 1.2×	14.9k 1.9×	10.0k 1.3×	6.9k 1.8×	2.5k 0.8×	336	29.8k
Masafumi Kitakaze Japan	74	8.2k 1.0×	3.8k 0.5×	6.1k 0.8×	1.7k 0.4×	2.8k 0.9×	474	19.4k
Charles Steenbergen United States	72	4.9k 0.6×	5.7k 0.7×	7.4k 0.9×	2.0k 0.5×	2.4k 0.8×	206	16.5k
David J. Lefer United States	80	5.4k 0.7×	5.6k 0.7×	7.2k 0.9×	1.4k 0.4×	7.4k 2.5×	286	24.7k
Tetsuji Miura Japan	58	4.1k 0.5×	3.5k 0.4×	4.1k 0.5×	1.6k 0.4×	1.7k 0.6×	393	12.7k
Derek M. Yellon United Kingdom	108	12.0k 1.5×	23.5k 2.9×	14.6k 1.9×	11.7k 3.0×	4.3k 1.4×	507	42.5k
Susumu Seino Japan	83	2.7k 0.3×	5.2k 0.6×	13.8k 1.8×	1.4k 0.4×	3.1k 1.0×	328	26.1k
Stephen F. Vatner United States	88	12.5k 1.5×	3.0k 0.4×	8.5k 1.1×	991 0.3×	3.7k 1.2×	402	23.7k

Countries citing papers authored by Rainer Schulz

Since Specialization

Citations

This map shows the geographic impact of Rainer Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Schulz more than expected).

Fields of papers citing papers by Rainer Schulz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Schulz. The network helps show where Rainer Schulz may publish in the future.

Co-authorship network of co-authors of Rainer Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Schulz. A scholar is included among the top collaborators of Rainer Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Schulz. Rainer Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Topouzis, Stavros, Andreas Papapetropoulos, S P H Alexander, et al.. (2025). Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review. British Journal of Pharmacology. 182(7). 1416–1445. 13 indexed citations

Heger, Jacqueline, Akylbek Sydykov, Astrid Weiß, et al.. (2024). Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?. International Journal of Molecular Sciences. 25(11). 6212–6212. 4 indexed citations

Izzo, Angelo A., Andreas Papapetropoulos, S P H Alexander, et al.. (2024). Natural product pharmacology: the British Journal of Pharmacology perspective. British Journal of Pharmacology. 181(19). 3547–3555. 34 indexed citations

Ferdinandy, Péter, Ioanna Andreadou, Gary F. Baxter, et al.. (2022). Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological Reviews. 75(1). 159–216. 81 indexed citations

Niemann, Bernd, Ruping Pan, Hassan Issa, et al.. (2022). AMPK Activation Is Indispensable for the Protective Effects of Caloric Restriction on Left Ventricular Function in Postinfarct Myocardium. Biology. 11(3). 448–448. 6 indexed citations

Euler, Gerhild, Jens Kockskämper, Rainer Schulz, & Mariana S. Parahuleva. (2021). JDP2, a Novel Molecular Key in Heart Failure and Atrial Fibrillation?. International Journal of Molecular Sciences. 22(8). 4110–4110. 3 indexed citations

Bornbaum, Julia, Klaus‐Dieter Schlüter, Alessandra Ghigo, et al.. (2021). PI3K as Mediator of Apoptosis and Contractile Dysfunction in TGFβ1-Stimulated Cardiomyocytes. Biology. 10(7). 670–670. 4 indexed citations

Smet, Maarten De, Nan Wang, Eef Dries, et al.. (2021). Cx43 hemichannel microdomain signaling at the intercalated disc enhances cardiac excitability. Journal of Clinical Investigation. 131(7). 60 indexed citations

Pesce, Maurizio, Piergiuseppe Agostoni, Hans Erik Bøtker, et al.. (2021). COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research. 117(10). 2148–2160. 26 indexed citations

10.

Brenner, Gábor B., András Makkos, Csilla Terézia Nagy, et al.. (2020). Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion. Cells. 9(3). 551–551. 18 indexed citations

11.

Schreckenberg, Rolf, Manuel Rebelo, Alexander Deten, et al.. (2015). Specific Mechanisms Underlying Right Heart Failure: The Missing Upregulation of Superoxide Dismutase-2 and Its Decisive Role in Antioxidative Defense. Antioxidants and Redox Signaling. 23(15). 1220–1232. 32 indexed citations

12.

Kleinbongard, Petra, Daniel Soetkamp, Jacqueline Heger, et al.. (2015). Interaction between Connexin 43 and nitric oxide synthase in mice heart mitochondria. Journal of Cellular and Molecular Medicine. 19(4). 815–825. 28 indexed citations

13.

Bornbaum, Julia, Nina Kaludercic, Roberta Menabò, et al.. (2015). NOX4 in Mitochondria: Yeast Two-Hybrid-Based Interaction with Complex I Without Relevance for Basal Reactive Oxygen Species?. Antioxidants and Redox Signaling. 23(14). 1106–1112. 40 indexed citations

14.

Aslam, Muhammad, Klaus‐Dieter Schlüter, Susanne Rohrbach, et al.. (2012). Hypoxia–reoxygenation‐induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. The Journal of Physiology. 591(2). 461–473. 48 indexed citations

15.

Groot, Herbert de, et al.. (2012). Mesenteric ischemia-reperfusion injury: Clearly improved hemodynamics but only minor protection of the rat small intestine by (sub)therapeutic heparin sodium and enoxaparin doses. Journal of Surgical Research. 179(1). e57–e69. 13 indexed citations

16.

Heusch, Gerd, Petra Kleinbongard, Andreas Skyschally, et al.. (2011). The coronary circulation in cardioprotection: more than just one confounder. Cardiovascular Research. 94(2). 237–245. 64 indexed citations

17.

Skyschally, Andreas, Patrick van Caster, Kerstin Boengler, et al.. (2008). Ischemic Postconditioning in Pigs. Circulation Research. 104(1). 15–18. 225 indexed citations

18.

Eltzschig, Holger K., Tobias Eckle, Christian Karcher, et al.. (2006). ATP Release From Activated Neutrophils Occurs via Connexin 43 and Modulates Adenosine-Dependent Endothelial Cell Function. Circulation Research. 99(10). 1100–1108. 300 indexed citations

19.

Rodríguez‐Sinovas, Antonio, Kerstin Boengler, Alberto Cabestrero, et al.. (2006). Translocation of Connexin 43 to the Inner Mitochondrial Membrane of Cardiomyocytes Through the Heat Shock Protein 90–Dependent TOM Pathway and Its Importance for Cardioprotection. Circulation Research. 99(1). 93–101. 208 indexed citations

20.

Heusch, Gerd & Rainer Schulz. (1996). New Paradigms of Coronary Artery Disease. Steinkopff eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact